Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 7, 2005; 11(33): 5199-5202
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5199
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5199
Unresectability | RCAS1 (%) | CEA (%) | CA19-9 (%) | RCAS1+CEA (%) | RCAS1+CA19-9 (%) | CA19-9+CEA (%) | ||||||
Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | |
Yes | 11 | 6 | 6 | 11 | 12 | 5 | 12 | 5 | 16 | 1 | 14 | 3 |
No | 1 | 4 | 0 | 5 | 4 | 1 | 1 | 4 | 5 | 0 | 4 | 1 |
Sensitivity | 65 | 35123 | 712 | 713 | 94b | 821 | ||||||
Specificity | 80 | 1004 | 20 | 80 | 0 | 20 | ||||||
Positive predictive value | 92 | 100 | 75 | 92 | 76 | 78 | ||||||
Negative predictive value | 40 | 31 | 17 | 44 | 0 | 25 | ||||||
Efficiency | 68 | 50 | 59 | 73 | 73 | 68 |
- Citation: Yamaguchi K, Enjoji M, Nakashima M, Nakamuta M, Watanabe T, Tanaka M. Novel serum tumor marker, RCAS1, in pancreatic diseases. World J Gastroenterol 2005; 11(33): 5199-5202
- URL: https://www.wjgnet.com/1007-9327/full/v11/i33/5199.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i33.5199